Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
College can be expensive, but saving money is possible. Learn practical ways to cut costs and keep your finances in check while studying.
27,554 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
The latest Trustees report reveals a $160.2 billion gap for 2025, forcing reserve use and signaling looming benefit p...
Warren Buffett’s blunt warning that today’s market mood resembles gambling hits a nerve with everyday investors. This...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
Berkshire Hathaway reduced its cash hoard to $373.3 billion by year-end 2025, a 2.1% drop from September, as Greg Abe...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
A new jobs report shows US payrolls fell in February even as energy costs surged and stocks slid, challenging the ide...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....
In 2026, two names inside the Magnificent Seven could deliver outsized AI gains that fly under the radar. This guide ...
Moomoo launches a refreshed free stock promotion in March 2026, offering Nvidia shares worth up to $1,000 for new cus...
Investors eyeing a $70,000 annual payout from investments are weighing dividend ETFs and fixed income. This guide bre...